Morten Praestegaard

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Atopic Dermatitis

Combination Therapy

Randomized Controlled Trial

Top Venues

Dermatology and therapy

Journal of the European Academy of Dermatology and Venereology : JEADV

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas Pinter, Linda F Stein Gold, Adam Reich, Lawrence J Green, Morten Praestegaard, Johan Selmer, April W Armstrong, Anne Danø, Sunil Dhawan, Jordi Galván, Sandra Elkjaer Stallknecht, Paw Trebbien, Matthias Augustin
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30 th EADV Congress 2021. Journal of the European Academy of Dermatology and Venereology : JEADV (2023)
Tiago Torres, Jordi Galván, Nigel Crutchley, Morten Praestegaard, Lars Iversen, Paolo Gisondi, Y José Manuel Carrascosa, Bruno Halioua, Anthony Bewley, Andreas Pinter
Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review. Dermatology and therapy (2023)
Zoe Diana Draelos, Matthew M Draelos, Fraser Steele, Michelle Georgiou, Morten Praestegaard
Enhanced Skin Deposition of Betamethasone Dipropionate from a Novel Formulation and Drug Delivery Technology. Dermatology and therapy (2023)
Morten Praestegaard, Fraser Steele, Nigel Crutchley
Polyaphron Dispersion Technology, A Novel Topical Formulation and Delivery System Combining Drug Penetration, Local Tolerability and Convenience of Application. Dermatology and therapy 12 (10) (2022)
Andreas Pinter, Linda F Stein Gold, Adam Reich, Lawrence J Green, Morten Praestegaard, Johan Selmer, April W Armstrong, Anne Danø, Sunil Dhawan, Jordi Galván, Sandra Elkjaer Stallknecht, Paw Trebbien, Matthias Augustin
A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30 th EADV Congress 2021. Journal of the European Academy of Dermatology and Venereology : JEADV (2022)